Elevated KATNB1 expression is associated with larger tumor size, lymph node metastasis, advanced cancer staging (TNM), and decreased rate of disease-free (DFS) and overall patient (OS) survival. This evidence concerns the gene KATNB1 and metastatic malignant neoplasm in the lymph nodes.